ケンタッキー州における喘息の臨床試験
ケンタッキー州内の拠点で、喘息に関する7件の研究が参加者を募集しています。
公式研究テキスト（英語）
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- GSK Investigational Site, Owensboro
被験者募集中第3相
12歳〜17歳 · 全性別 · 2026/09/30更新 · NCT05757102A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
- GSK Investigational Site, Owensboro
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07645248Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Research Site, Louisville
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT06932263ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, Owensboro
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/24更新 · NCT07301255A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- Allergy & Asthma Specialists, P.S.C., Owensboro
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/22更新 · NCT07219173A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Owensboro
被験者募集中第2相
4歳〜11歳 · 全性別 · 2026/08/27更新 · NCT07525375Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Louisville
- Research Site, Louisville
被験者募集中第3相
12歳〜17歳 · 全性別 · 2026/08/13更新 · NCT06307665ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。